ALKERMES | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 36.4B 2.35B 2025-03
Acadia Pharmaceuticals USD 330.02M 27.49M 2025-06
ALKERMES USD 505.96M 62.23M 2025-06
Amgen USD 20.48B 2.53B 2025-06
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Eli Lilly USD 39.02B 8.95B 2025-06
Gilead Sciences USD 11.19B 1.15B 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
J&J USD 56.9B 6.58B 2025-03
Malin Corporation EUR 1000K 500K 2024-12
Merck USD 26.04B 863M 2025-06
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
Otsuka Holdings JPY 675.84B 25.89B 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06


ALKERMES Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.